nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Acitretin—psoriasis	0.0719	0.116	CbGbCtD
Clomipramine—CYP1A2—Clobetasol propionate—psoriasis	0.0668	0.108	CbGbCtD
Clomipramine—CYP1A2—Methoxsalen—psoriasis	0.0351	0.0568	CbGbCtD
Clomipramine—ALB—Mycophenolate mofetil—psoriasis	0.0337	0.0545	CbGbCtD
Clomipramine—CYP2D6—Hydroxyurea—psoriasis	0.0316	0.0511	CbGbCtD
Clomipramine—ALB—Prednisone—psoriasis	0.0269	0.0436	CbGbCtD
Clomipramine—CYP2C19—Cholecalciferol—psoriasis	0.0252	0.0407	CbGbCtD
Clomipramine—CYP3A4—Calcitriol—psoriasis	0.0236	0.0382	CbGbCtD
Clomipramine—CYP2D6—Cholecalciferol—psoriasis	0.0191	0.031	CbGbCtD
Clomipramine—CYP3A4—Methoxsalen—psoriasis	0.0184	0.0297	CbGbCtD
Clomipramine—ABCB1—Mycophenolate mofetil—psoriasis	0.0176	0.0285	CbGbCtD
Clomipramine—CYP2C19—Prednisone—psoriasis	0.0175	0.0282	CbGbCtD
Clomipramine—CYP2C19—Cyclosporine—psoriasis	0.0165	0.0268	CbGbCtD
Clomipramine—ABCB1—Betamethasone—psoriasis	0.0151	0.0245	CbGbCtD
Clomipramine—ABCB1—Prednisolone—psoriasis	0.0149	0.0241	CbGbCtD
Clomipramine—ABCB1—Hydrocortisone—psoriasis	0.0141	0.0229	CbGbCtD
Clomipramine—ABCB1—Prednisone—psoriasis	0.0141	0.0228	CbGbCtD
Clomipramine—ALB—Methotrexate—psoriasis	0.0135	0.0219	CbGbCtD
Clomipramine—ABCB1—Cyclosporine—psoriasis	0.0133	0.0216	CbGbCtD
Clomipramine—CYP2D6—Cyclosporine—psoriasis	0.0126	0.0204	CbGbCtD
Clomipramine—CYP3A4—Cholecalciferol—psoriasis	0.0122	0.0197	CbGbCtD
Clomipramine—CYP2C19—Dexamethasone—psoriasis	0.0109	0.0176	CbGbCtD
Clomipramine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0106	0.0171	CbGbCtD
Clomipramine—CYP3A4—Triamcinolone—psoriasis	0.0106	0.0171	CbGbCtD
Clomipramine—CYP3A4—Betamethasone—psoriasis	0.00905	0.0147	CbGbCtD
Clomipramine—CYP3A4—Prednisolone—psoriasis	0.00893	0.0145	CbGbCtD
Clomipramine—ABCB1—Dexamethasone—psoriasis	0.00879	0.0142	CbGbCtD
Clomipramine—CYP3A4—Hydrocortisone—psoriasis	0.00847	0.0137	CbGbCtD
Clomipramine—CYP3A4—Prednisone—psoriasis	0.00844	0.0137	CbGbCtD
Clomipramine—CYP2D6—Dexamethasone—psoriasis	0.00828	0.0134	CbGbCtD
Clomipramine—CYP3A4—Cyclosporine—psoriasis	0.008	0.0129	CbGbCtD
Clomipramine—ABCB1—Methotrexate—psoriasis	0.00706	0.0114	CbGbCtD
Clomipramine—CYP3A4—Dexamethasone—psoriasis	0.00527	0.00852	CbGbCtD
Clomipramine—Anxiety—Dexamethasone—psoriasis	6.39e-05	0.00018	CcSEcCtD
Clomipramine—Anxiety—Betamethasone—psoriasis	6.39e-05	0.00018	CcSEcCtD
Clomipramine—Vomiting—Mycophenolic acid—psoriasis	6.36e-05	0.000179	CcSEcCtD
Clomipramine—Discomfort—Dexamethasone—psoriasis	6.33e-05	0.000179	CcSEcCtD
Clomipramine—Discomfort—Betamethasone—psoriasis	6.33e-05	0.000179	CcSEcCtD
Clomipramine—Dyspepsia—Hydrocortisone—psoriasis	6.33e-05	0.000178	CcSEcCtD
Clomipramine—Rash—Mycophenolic acid—psoriasis	6.31e-05	0.000178	CcSEcCtD
Clomipramine—Dermatitis—Mycophenolic acid—psoriasis	6.3e-05	0.000178	CcSEcCtD
Clomipramine—Pain—Prednisolone—psoriasis	6.3e-05	0.000178	CcSEcCtD
Clomipramine—Hepatitis—Methotrexate—psoriasis	6.29e-05	0.000177	CcSEcCtD
Clomipramine—Urticaria—Mycophenolate mofetil—psoriasis	6.27e-05	0.000177	CcSEcCtD
Clomipramine—Headache—Mycophenolic acid—psoriasis	6.26e-05	0.000177	CcSEcCtD
Clomipramine—Decreased appetite—Hydrocortisone—psoriasis	6.25e-05	0.000176	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—psoriasis	6.25e-05	0.000176	CcSEcCtD
Clomipramine—Abdominal pain—Mycophenolate mofetil—psoriasis	6.24e-05	0.000176	CcSEcCtD
Clomipramine—Body temperature increased—Mycophenolate mofetil—psoriasis	6.24e-05	0.000176	CcSEcCtD
Clomipramine—Urinary tract disorder—Methotrexate—psoriasis	6.21e-05	0.000175	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.21e-05	0.000175	CcSEcCtD
Clomipramine—Fatigue—Hydrocortisone—psoriasis	6.2e-05	0.000175	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—psoriasis	6.18e-05	0.000174	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—psoriasis	6.17e-05	0.000174	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.17e-05	0.000174	CcSEcCtD
Clomipramine—Pain—Hydrocortisone—psoriasis	6.15e-05	0.000173	CcSEcCtD
Clomipramine—Oedema—Dexamethasone—psoriasis	6.14e-05	0.000173	CcSEcCtD
Clomipramine—Anaphylactic shock—Betamethasone—psoriasis	6.14e-05	0.000173	CcSEcCtD
Clomipramine—Oedema—Betamethasone—psoriasis	6.14e-05	0.000173	CcSEcCtD
Clomipramine—Anaphylactic shock—Dexamethasone—psoriasis	6.14e-05	0.000173	CcSEcCtD
Clomipramine—Insomnia—Triamcinolone—psoriasis	6.12e-05	0.000173	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—psoriasis	6.08e-05	0.000172	CcSEcCtD
Clomipramine—Paraesthesia—Triamcinolone—psoriasis	6.08e-05	0.000171	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisolone—psoriasis	6.07e-05	0.000171	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—psoriasis	6.06e-05	0.000171	CcSEcCtD
Clomipramine—Anaemia—Prednisone—psoriasis	6.06e-05	0.000171	CcSEcCtD
Clomipramine—Shock—Betamethasone—psoriasis	6.04e-05	0.00017	CcSEcCtD
Clomipramine—Shock—Dexamethasone—psoriasis	6.04e-05	0.00017	CcSEcCtD
Clomipramine—Dyspnoea—Triamcinolone—psoriasis	6.04e-05	0.00017	CcSEcCtD
Clomipramine—Nervous system disorder—Betamethasone—psoriasis	6.02e-05	0.00017	CcSEcCtD
Clomipramine—Nervous system disorder—Dexamethasone—psoriasis	6.02e-05	0.00017	CcSEcCtD
Clomipramine—Agitation—Prednisone—psoriasis	6.02e-05	0.00017	CcSEcCtD
Clomipramine—Thrombocytopenia—Betamethasone—psoriasis	6.01e-05	0.00017	CcSEcCtD
Clomipramine—Thrombocytopenia—Dexamethasone—psoriasis	6.01e-05	0.00017	CcSEcCtD
Clomipramine—Tachycardia—Dexamethasone—psoriasis	6e-05	0.000169	CcSEcCtD
Clomipramine—Tachycardia—Betamethasone—psoriasis	6e-05	0.000169	CcSEcCtD
Clomipramine—Hypersensitivity—Cyclosporine—psoriasis	5.96e-05	0.000168	CcSEcCtD
Clomipramine—Dyspepsia—Triamcinolone—psoriasis	5.96e-05	0.000168	CcSEcCtD
Clomipramine—Nausea—Mycophenolic acid—psoriasis	5.94e-05	0.000168	CcSEcCtD
Clomipramine—Hyperhidrosis—Betamethasone—psoriasis	5.94e-05	0.000167	CcSEcCtD
Clomipramine—Hyperhidrosis—Dexamethasone—psoriasis	5.94e-05	0.000167	CcSEcCtD
Clomipramine—Feeling abnormal—Hydrocortisone—psoriasis	5.92e-05	0.000167	CcSEcCtD
Clomipramine—Malaise—Prednisone—psoriasis	5.91e-05	0.000167	CcSEcCtD
Clomipramine—Vertigo—Prednisone—psoriasis	5.89e-05	0.000166	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—psoriasis	5.88e-05	0.000166	CcSEcCtD
Clomipramine—Gastrointestinal pain—Hydrocortisone—psoriasis	5.88e-05	0.000166	CcSEcCtD
Clomipramine—Syncope—Prednisone—psoriasis	5.88e-05	0.000166	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—psoriasis	5.87e-05	0.000165	CcSEcCtD
Clomipramine—Anorexia—Dexamethasone—psoriasis	5.86e-05	0.000165	CcSEcCtD
Clomipramine—Anorexia—Betamethasone—psoriasis	5.86e-05	0.000165	CcSEcCtD
Clomipramine—Urticaria—Prednisolone—psoriasis	5.85e-05	0.000165	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—psoriasis	5.84e-05	0.000165	CcSEcCtD
Clomipramine—Fatigue—Triamcinolone—psoriasis	5.84e-05	0.000165	CcSEcCtD
Clomipramine—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.81e-05	0.000164	CcSEcCtD
Clomipramine—Asthenia—Cyclosporine—psoriasis	5.8e-05	0.000164	CcSEcCtD
Clomipramine—Pain—Triamcinolone—psoriasis	5.79e-05	0.000163	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—psoriasis	5.76e-05	0.000162	CcSEcCtD
Clomipramine—Hypotension—Dexamethasone—psoriasis	5.74e-05	0.000162	CcSEcCtD
Clomipramine—Hypotension—Betamethasone—psoriasis	5.74e-05	0.000162	CcSEcCtD
Clomipramine—Pruritus—Cyclosporine—psoriasis	5.72e-05	0.000161	CcSEcCtD
Clomipramine—Urticaria—Hydrocortisone—psoriasis	5.71e-05	0.000161	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—psoriasis	5.71e-05	0.000161	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—psoriasis	5.68e-05	0.00016	CcSEcCtD
Clomipramine—Body temperature increased—Hydrocortisone—psoriasis	5.68e-05	0.00016	CcSEcCtD
Clomipramine—Abdominal pain—Hydrocortisone—psoriasis	5.68e-05	0.00016	CcSEcCtD
Clomipramine—Convulsion—Prednisone—psoriasis	5.68e-05	0.00016	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—psoriasis	5.67e-05	0.00016	CcSEcCtD
Clomipramine—Asthenia—Mycophenolate mofetil—psoriasis	5.66e-05	0.00016	CcSEcCtD
Clomipramine—Hypertension—Prednisone—psoriasis	5.66e-05	0.00016	CcSEcCtD
Clomipramine—Chills—Methotrexate—psoriasis	5.65e-05	0.000159	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Betamethasone—psoriasis	5.6e-05	0.000158	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.6e-05	0.000158	CcSEcCtD
Clomipramine—Pruritus—Mycophenolate mofetil—psoriasis	5.58e-05	0.000157	CcSEcCtD
Clomipramine—Myalgia—Prednisone—psoriasis	5.58e-05	0.000157	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—psoriasis	5.58e-05	0.000157	CcSEcCtD
Clomipramine—Feeling abnormal—Triamcinolone—psoriasis	5.58e-05	0.000157	CcSEcCtD
Clomipramine—Anxiety—Prednisone—psoriasis	5.56e-05	0.000157	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—psoriasis	5.56e-05	0.000157	CcSEcCtD
Clomipramine—Insomnia—Dexamethasone—psoriasis	5.56e-05	0.000157	CcSEcCtD
Clomipramine—Insomnia—Betamethasone—psoriasis	5.56e-05	0.000157	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.54e-05	0.000156	CcSEcCtD
Clomipramine—Diarrhoea—Cyclosporine—psoriasis	5.54e-05	0.000156	CcSEcCtD
Clomipramine—Paraesthesia—Betamethasone—psoriasis	5.52e-05	0.000156	CcSEcCtD
Clomipramine—Paraesthesia—Dexamethasone—psoriasis	5.52e-05	0.000156	CcSEcCtD
Clomipramine—Discomfort—Prednisone—psoriasis	5.51e-05	0.000155	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—psoriasis	5.51e-05	0.000155	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—psoriasis	5.48e-05	0.000154	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisolone—psoriasis	5.42e-05	0.000153	CcSEcCtD
Clomipramine—Dyspepsia—Betamethasone—psoriasis	5.41e-05	0.000152	CcSEcCtD
Clomipramine—Dyspepsia—Dexamethasone—psoriasis	5.41e-05	0.000152	CcSEcCtD
Clomipramine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.4e-05	0.000152	CcSEcCtD
Clomipramine—Urticaria—Triamcinolone—psoriasis	5.38e-05	0.000152	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—psoriasis	5.36e-05	0.000151	CcSEcCtD
Clomipramine—Body temperature increased—Triamcinolone—psoriasis	5.35e-05	0.000151	CcSEcCtD
Clomipramine—Dizziness—Cyclosporine—psoriasis	5.35e-05	0.000151	CcSEcCtD
Clomipramine—Oedema—Prednisone—psoriasis	5.35e-05	0.000151	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—psoriasis	5.35e-05	0.000151	CcSEcCtD
Clomipramine—Decreased appetite—Betamethasone—psoriasis	5.34e-05	0.000151	CcSEcCtD
Clomipramine—Decreased appetite—Dexamethasone—psoriasis	5.34e-05	0.000151	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Betamethasone—psoriasis	5.3e-05	0.00015	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Dexamethasone—psoriasis	5.3e-05	0.00015	CcSEcCtD
Clomipramine—Back pain—Methotrexate—psoriasis	5.3e-05	0.000149	CcSEcCtD
Clomipramine—Hypersensitivity—Hydrocortisone—psoriasis	5.3e-05	0.000149	CcSEcCtD
Clomipramine—Fatigue—Dexamethasone—psoriasis	5.3e-05	0.000149	CcSEcCtD
Clomipramine—Fatigue—Betamethasone—psoriasis	5.3e-05	0.000149	CcSEcCtD
Clomipramine—Shock—Prednisone—psoriasis	5.26e-05	0.000148	CcSEcCtD
Clomipramine—Pain—Dexamethasone—psoriasis	5.25e-05	0.000148	CcSEcCtD
Clomipramine—Pain—Betamethasone—psoriasis	5.25e-05	0.000148	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—psoriasis	5.25e-05	0.000148	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—psoriasis	5.22e-05	0.000147	CcSEcCtD
Clomipramine—Dizziness—Mycophenolate mofetil—psoriasis	5.22e-05	0.000147	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—psoriasis	5.2e-05	0.000147	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—psoriasis	5.17e-05	0.000146	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—psoriasis	5.16e-05	0.000146	CcSEcCtD
Clomipramine—Asthenia—Hydrocortisone—psoriasis	5.16e-05	0.000145	CcSEcCtD
Clomipramine—Vomiting—Cyclosporine—psoriasis	5.14e-05	0.000145	CcSEcCtD
Clomipramine—Rash—Cyclosporine—psoriasis	5.1e-05	0.000144	CcSEcCtD
Clomipramine—Anorexia—Prednisone—psoriasis	5.1e-05	0.000144	CcSEcCtD
Clomipramine—Dermatitis—Cyclosporine—psoriasis	5.1e-05	0.000144	CcSEcCtD
Clomipramine—Pruritus—Hydrocortisone—psoriasis	5.09e-05	0.000143	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—psoriasis	5.08e-05	0.000143	CcSEcCtD
Clomipramine—Headache—Cyclosporine—psoriasis	5.07e-05	0.000143	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—psoriasis	5.06e-05	0.000143	CcSEcCtD
Clomipramine—Feeling abnormal—Betamethasone—psoriasis	5.06e-05	0.000143	CcSEcCtD
Clomipramine—Feeling abnormal—Dexamethasone—psoriasis	5.06e-05	0.000143	CcSEcCtD
Clomipramine—Gastrointestinal pain—Betamethasone—psoriasis	5.02e-05	0.000142	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dexamethasone—psoriasis	5.02e-05	0.000142	CcSEcCtD
Clomipramine—Vomiting—Mycophenolate mofetil—psoriasis	5.02e-05	0.000142	CcSEcCtD
Clomipramine—Hypersensitivity—Triamcinolone—psoriasis	4.99e-05	0.000141	CcSEcCtD
Clomipramine—Rash—Mycophenolate mofetil—psoriasis	4.98e-05	0.00014	CcSEcCtD
Clomipramine—Dermatitis—Mycophenolate mofetil—psoriasis	4.97e-05	0.00014	CcSEcCtD
Clomipramine—Headache—Mycophenolate mofetil—psoriasis	4.94e-05	0.000139	CcSEcCtD
Clomipramine—Malaise—Methotrexate—psoriasis	4.94e-05	0.000139	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—psoriasis	4.92e-05	0.000139	CcSEcCtD
Clomipramine—Diarrhoea—Hydrocortisone—psoriasis	4.92e-05	0.000139	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—psoriasis	4.9e-05	0.000138	CcSEcCtD
Clomipramine—Urticaria—Betamethasone—psoriasis	4.88e-05	0.000138	CcSEcCtD
Clomipramine—Urticaria—Dexamethasone—psoriasis	4.88e-05	0.000138	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Prednisone—psoriasis	4.87e-05	0.000137	CcSEcCtD
Clomipramine—Dizziness—Prednisolone—psoriasis	4.87e-05	0.000137	CcSEcCtD
Clomipramine—Asthenia—Triamcinolone—psoriasis	4.86e-05	0.000137	CcSEcCtD
Clomipramine—Abdominal pain—Dexamethasone—psoriasis	4.86e-05	0.000137	CcSEcCtD
Clomipramine—Body temperature increased—Betamethasone—psoriasis	4.86e-05	0.000137	CcSEcCtD
Clomipramine—Abdominal pain—Betamethasone—psoriasis	4.86e-05	0.000137	CcSEcCtD
Clomipramine—Body temperature increased—Dexamethasone—psoriasis	4.86e-05	0.000137	CcSEcCtD
Clomipramine—Insomnia—Prednisone—psoriasis	4.84e-05	0.000136	CcSEcCtD
Clomipramine—Nausea—Cyclosporine—psoriasis	4.81e-05	0.000136	CcSEcCtD
Clomipramine—Paraesthesia—Prednisone—psoriasis	4.8e-05	0.000135	CcSEcCtD
Clomipramine—Pruritus—Triamcinolone—psoriasis	4.79e-05	0.000135	CcSEcCtD
Clomipramine—Cough—Methotrexate—psoriasis	4.78e-05	0.000135	CcSEcCtD
Clomipramine—Dizziness—Hydrocortisone—psoriasis	4.75e-05	0.000134	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—psoriasis	4.75e-05	0.000134	CcSEcCtD
Clomipramine—Dyspepsia—Prednisone—psoriasis	4.71e-05	0.000133	CcSEcCtD
Clomipramine—Nausea—Mycophenolate mofetil—psoriasis	4.69e-05	0.000132	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—psoriasis	4.66e-05	0.000132	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—psoriasis	4.66e-05	0.000132	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—psoriasis	4.66e-05	0.000132	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—psoriasis	4.65e-05	0.000131	CcSEcCtD
Clomipramine—Rash—Prednisolone—psoriasis	4.64e-05	0.000131	CcSEcCtD
Clomipramine—Dermatitis—Prednisolone—psoriasis	4.64e-05	0.000131	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.63e-05	0.000131	CcSEcCtD
Clomipramine—Fatigue—Prednisone—psoriasis	4.61e-05	0.00013	CcSEcCtD
Clomipramine—Headache—Prednisolone—psoriasis	4.61e-05	0.00013	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—psoriasis	4.61e-05	0.00013	CcSEcCtD
Clomipramine—Constipation—Prednisone—psoriasis	4.57e-05	0.000129	CcSEcCtD
Clomipramine—Vomiting—Hydrocortisone—psoriasis	4.57e-05	0.000129	CcSEcCtD
Clomipramine—Rash—Hydrocortisone—psoriasis	4.53e-05	0.000128	CcSEcCtD
Clomipramine—Dermatitis—Hydrocortisone—psoriasis	4.53e-05	0.000128	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—psoriasis	4.51e-05	0.000127	CcSEcCtD
Clomipramine—Headache—Hydrocortisone—psoriasis	4.5e-05	0.000127	CcSEcCtD
Clomipramine—Dizziness—Triamcinolone—psoriasis	4.48e-05	0.000126	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—psoriasis	4.47e-05	0.000126	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisone—psoriasis	4.41e-05	0.000124	CcSEcCtD
Clomipramine—Asthenia—Betamethasone—psoriasis	4.41e-05	0.000124	CcSEcCtD
Clomipramine—Asthenia—Dexamethasone—psoriasis	4.41e-05	0.000124	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—psoriasis	4.38e-05	0.000124	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—psoriasis	4.38e-05	0.000123	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—psoriasis	4.37e-05	0.000123	CcSEcCtD
Clomipramine—Nausea—Prednisolone—psoriasis	4.37e-05	0.000123	CcSEcCtD
Clomipramine—Pruritus—Dexamethasone—psoriasis	4.35e-05	0.000123	CcSEcCtD
Clomipramine—Pruritus—Betamethasone—psoriasis	4.35e-05	0.000123	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—psoriasis	4.34e-05	0.000122	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—psoriasis	4.32e-05	0.000122	CcSEcCtD
Clomipramine—Vomiting—Triamcinolone—psoriasis	4.3e-05	0.000121	CcSEcCtD
Clomipramine—HTR2B—Signaling Pathways—HCAR2—psoriasis	4.3e-05	0.00157	CbGpPWpGaD
Clomipramine—Nausea—Hydrocortisone—psoriasis	4.27e-05	0.00012	CcSEcCtD
Clomipramine—Rash—Triamcinolone—psoriasis	4.27e-05	0.00012	CcSEcCtD
Clomipramine—Dermatitis—Triamcinolone—psoriasis	4.26e-05	0.00012	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—psoriasis	4.26e-05	0.00012	CcSEcCtD
Clomipramine—Urticaria—Prednisone—psoriasis	4.25e-05	0.00012	CcSEcCtD
Clomipramine—Headache—Triamcinolone—psoriasis	4.24e-05	0.00012	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—psoriasis	4.23e-05	0.000119	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—psoriasis	4.23e-05	0.000119	CcSEcCtD
Clomipramine—Diarrhoea—Betamethasone—psoriasis	4.2e-05	0.000119	CcSEcCtD
Clomipramine—Diarrhoea—Dexamethasone—psoriasis	4.2e-05	0.000119	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—psoriasis	4.18e-05	0.000118	CcSEcCtD
Clomipramine—HTR2B—GPCR downstream signaling—CCL20—psoriasis	4.16e-05	0.00152	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CCL20—psoriasis	4.14e-05	0.00151	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—NFKB1—psoriasis	4.08e-05	0.00149	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TAGAP—psoriasis	4.08e-05	0.00149	CbGpPWpGaD
Clomipramine—Musculoskeletal discomfort—Methotrexate—psoriasis	4.07e-05	0.000115	CcSEcCtD
Clomipramine—Dizziness—Betamethasone—psoriasis	4.06e-05	0.000115	CcSEcCtD
Clomipramine—Dizziness—Dexamethasone—psoriasis	4.06e-05	0.000115	CcSEcCtD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	4.05e-05	0.00148	CbGpPWpGaD
Clomipramine—Insomnia—Methotrexate—psoriasis	4.04e-05	0.000114	CcSEcCtD
Clomipramine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	4.03e-05	0.00147	CbGpPWpGaD
Clomipramine—Nausea—Triamcinolone—psoriasis	4.02e-05	0.000113	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—psoriasis	4.01e-05	0.000113	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—psoriasis	3.99e-05	0.000112	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—psoriasis	3.97e-05	0.000112	CcSEcCtD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.96e-05	0.00144	CbGpPWpGaD
Clomipramine—Hypersensitivity—Prednisone—psoriasis	3.94e-05	0.000111	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—psoriasis	3.94e-05	0.000111	CcSEcCtD
Clomipramine—Vomiting—Betamethasone—psoriasis	3.91e-05	0.00011	CcSEcCtD
Clomipramine—Vomiting—Dexamethasone—psoriasis	3.91e-05	0.00011	CcSEcCtD
Clomipramine—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.9e-05	0.00142	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.9e-05	0.00142	CbGpPWpGaD
Clomipramine—Decreased appetite—Methotrexate—psoriasis	3.89e-05	0.00011	CcSEcCtD
Clomipramine—Rash—Betamethasone—psoriasis	3.87e-05	0.000109	CcSEcCtD
Clomipramine—Rash—Dexamethasone—psoriasis	3.87e-05	0.000109	CcSEcCtD
Clomipramine—ADRA2A—Hemostasis—ITGAL—psoriasis	3.87e-05	0.00141	CbGpPWpGaD
Clomipramine—Dermatitis—Dexamethasone—psoriasis	3.87e-05	0.000109	CcSEcCtD
Clomipramine—Dermatitis—Betamethasone—psoriasis	3.87e-05	0.000109	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—psoriasis	3.86e-05	0.000109	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—psoriasis	3.85e-05	0.000109	CcSEcCtD
Clomipramine—Headache—Betamethasone—psoriasis	3.85e-05	0.000109	CcSEcCtD
Clomipramine—Headache—Dexamethasone—psoriasis	3.85e-05	0.000109	CcSEcCtD
Clomipramine—Asthenia—Prednisone—psoriasis	3.84e-05	0.000108	CcSEcCtD
Clomipramine—Pain—Methotrexate—psoriasis	3.82e-05	0.000108	CcSEcCtD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.81e-05	0.00139	CbGpPWpGaD
Clomipramine—Pruritus—Prednisone—psoriasis	3.78e-05	0.000107	CcSEcCtD
Clomipramine—HTR2B—Signaling by GPCR—CCL20—psoriasis	3.78e-05	0.00138	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.73e-05	0.00136	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TAGAP—psoriasis	3.73e-05	0.00136	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.72e-05	0.00136	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.72e-05	0.00136	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	3.69e-05	0.00135	CbGpPWpGaD
Clomipramine—Feeling abnormal—Methotrexate—psoriasis	3.68e-05	0.000104	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—psoriasis	3.66e-05	0.000103	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—psoriasis	3.66e-05	0.000103	CcSEcCtD
Clomipramine—Nausea—Dexamethasone—psoriasis	3.65e-05	0.000103	CcSEcCtD
Clomipramine—Nausea—Betamethasone—psoriasis	3.65e-05	0.000103	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—psoriasis	3.55e-05	0.0001	CcSEcCtD
Clomipramine—Dizziness—Prednisone—psoriasis	3.54e-05	9.98e-05	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—psoriasis	3.53e-05	9.97e-05	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—psoriasis	3.53e-05	9.97e-05	CcSEcCtD
Clomipramine—GSTP1—Cellular responses to stress—TP53—psoriasis	3.51e-05	0.00128	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NDUFA5—psoriasis	3.48e-05	0.00127	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HCAR2—psoriasis	3.47e-05	0.00126	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.46e-05	0.00126	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.46e-05	0.00126	CbGpPWpGaD
Clomipramine—Vomiting—Prednisone—psoriasis	3.4e-05	9.59e-05	CcSEcCtD
Clomipramine—Rash—Prednisone—psoriasis	3.37e-05	9.51e-05	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—psoriasis	3.37e-05	9.5e-05	CcSEcCtD
Clomipramine—HTR2C—GPCR downstream signaling—CCL20—psoriasis	3.36e-05	0.00122	CbGpPWpGaD
Clomipramine—Headache—Prednisone—psoriasis	3.35e-05	9.45e-05	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—psoriasis	3.29e-05	9.29e-05	CcSEcCtD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	3.27e-05	0.00119	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.25e-05	0.00118	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.24e-05	0.00118	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—IL6—psoriasis	3.22e-05	0.00117	CbGpPWpGaD
Clomipramine—Asthenia—Methotrexate—psoriasis	3.21e-05	9.05e-05	CcSEcCtD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.19e-05	0.00116	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCL20—psoriasis	3.19e-05	0.00116	CbGpPWpGaD
Clomipramine—Nausea—Prednisone—psoriasis	3.18e-05	8.96e-05	CcSEcCtD
Clomipramine—ALB—Platelet degranulation—VEGFA—psoriasis	3.18e-05	0.00116	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—TNF—psoriasis	3.18e-05	0.00116	CbGpPWpGaD
Clomipramine—Pruritus—Methotrexate—psoriasis	3.16e-05	8.92e-05	CcSEcCtD
Clomipramine—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.15e-05	0.00115	CbGpPWpGaD
Clomipramine—Diarrhoea—Methotrexate—psoriasis	3.06e-05	8.63e-05	CcSEcCtD
Clomipramine—ALB—Hemostasis—ITGAL—psoriasis	3.06e-05	0.00112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CCL20—psoriasis	3.05e-05	0.00111	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.03e-05	0.0011	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HCAR2—psoriasis	3.01e-05	0.0011	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TAGAP—psoriasis	3.01e-05	0.0011	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	2.98e-05	0.00109	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—JUN—psoriasis	2.97e-05	0.00108	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.96e-05	0.00108	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.96e-05	0.00108	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP2S1—psoriasis	2.96e-05	0.00108	CbGpPWpGaD
Clomipramine—Dizziness—Methotrexate—psoriasis	2.96e-05	8.34e-05	CcSEcCtD
Clomipramine—HTR2A—GPCR downstream signaling—CCL20—psoriasis	2.91e-05	0.00106	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.86e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.86e-05	0.00104	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.85e-05	0.00104	CbGpPWpGaD
Clomipramine—Vomiting—Methotrexate—psoriasis	2.84e-05	8.02e-05	CcSEcCtD
Clomipramine—HRH2—GPCR ligand binding—CXCL8—psoriasis	2.84e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.84e-05	0.00104	CbGpPWpGaD
Clomipramine—Rash—Methotrexate—psoriasis	2.82e-05	7.95e-05	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—psoriasis	2.82e-05	7.94e-05	CcSEcCtD
Clomipramine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.81e-05	0.00103	CbGpPWpGaD
Clomipramine—Headache—Methotrexate—psoriasis	2.8e-05	7.9e-05	CcSEcCtD
Clomipramine—ALB—Folate Metabolism—TP53—psoriasis	2.8e-05	0.00102	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NDUFA5—psoriasis	2.75e-05	0.001	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HCAR2—psoriasis	2.74e-05	0.000999	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CAT—psoriasis	2.67e-05	0.000975	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	2.66e-05	0.00097	CbGpPWpGaD
Clomipramine—Nausea—Methotrexate—psoriasis	2.66e-05	7.49e-05	CcSEcCtD
Clomipramine—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	2.65e-05	0.000968	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL20—psoriasis	2.65e-05	0.000966	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.61e-05	0.000953	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TAGAP—psoriasis	2.61e-05	0.000952	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.59e-05	0.000946	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.56e-05	0.000935	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—IL6—psoriasis	2.56e-05	0.000935	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.55e-05	0.000932	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.52e-05	0.00092	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NDUFA5—psoriasis	2.47e-05	0.000901	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL20—psoriasis	2.45e-05	0.000892	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.44e-05	0.000889	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	2.43e-05	0.000888	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—TNF—psoriasis	2.41e-05	0.000879	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NDUFA5—psoriasis	2.41e-05	0.000879	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL20—psoriasis	2.41e-05	0.000879	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.4e-05	0.000874	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TAGAP—psoriasis	2.37e-05	0.000866	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP2S1—psoriasis	2.34e-05	0.000853	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.3e-05	0.00084	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.27e-05	0.000828	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.24e-05	0.000817	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL20—psoriasis	2.23e-05	0.000814	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	2.22e-05	0.000811	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—CXCL8—psoriasis	2.18e-05	0.000795	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.14e-05	0.000779	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.11e-05	0.000769	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.1e-05	0.000766	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	2.09e-05	0.000764	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—APOE—psoriasis	2.08e-05	0.000757	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2S1—psoriasis	2.05e-05	0.000747	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.04e-05	0.000743	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—CXCL8—psoriasis	1.99e-05	0.000725	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.98e-05	0.000723	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.93e-05	0.000704	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.92e-05	0.000702	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.83e-05	0.000667	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PPARG—psoriasis	1.81e-05	0.00066	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL20—psoriasis	1.8e-05	0.000657	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	1.79e-05	0.000654	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.79e-05	0.000654	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.79e-05	0.000651	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SOCS1—psoriasis	1.76e-05	0.000641	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TYK2—psoriasis	1.67e-05	0.000611	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.66e-05	0.000607	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.64e-05	0.000597	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—CXCL8—psoriasis	1.6e-05	0.000586	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—CXCL8—psoriasis	1.6e-05	0.000585	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.6e-05	0.000583	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—NOS2—psoriasis	1.59e-05	0.00058	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.59e-05	0.000579	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL20—psoriasis	1.56e-05	0.000571	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.53e-05	0.000558	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.48e-05	0.000542	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—CXCL8—psoriasis	1.46e-05	0.000532	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CARM1—psoriasis	1.45e-05	0.000528	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL20—psoriasis	1.42e-05	0.000519	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.41e-05	0.000514	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	1.39e-05	0.000508	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.39e-05	0.000506	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.39e-05	0.000506	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SOCS1—psoriasis	1.35e-05	0.000491	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APOE—psoriasis	1.3e-05	0.000473	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—LEP—psoriasis	1.3e-05	0.000473	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TYK2—psoriasis	1.28e-05	0.000468	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	1.27e-05	0.000462	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.26e-05	0.00046	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—NOS2—psoriasis	1.25e-05	0.000458	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—CXCL8—psoriasis	1.23e-05	0.000449	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SOCS1—psoriasis	1.23e-05	0.000448	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.23e-05	0.000447	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NFKBIA—psoriasis	1.21e-05	0.00044	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.19e-05	0.000434	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TYK2—psoriasis	1.17e-05	0.000428	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CARM1—psoriasis	1.14e-05	0.000417	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	1.12e-05	0.00041	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CXCL8—psoriasis	1.12e-05	0.000408	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.1e-05	0.000401	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000389	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.05e-05	0.000383	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CARM1—psoriasis	1.02e-05	0.000374	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CXCL8—psoriasis	1.02e-05	0.000372	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CARM1—psoriasis	1e-05	0.000365	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APOE—psoriasis	9.94e-06	0.000363	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—LEP—psoriasis	9.94e-06	0.000363	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SOCS1—psoriasis	9.91e-06	0.000362	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TYK2—psoriasis	9.89e-06	0.000361	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.58e-06	0.00035	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TYK2—psoriasis	9.45e-06	0.000345	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CARM1—psoriasis	9.43e-06	0.000344	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NFKBIA—psoriasis	9.26e-06	0.000338	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—psoriasis	9.2e-06	0.000336	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—psoriasis	9.07e-06	0.000331	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEP—psoriasis	9.07e-06	0.000331	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	9.06e-06	0.000331	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CAT—psoriasis	8.9e-06	0.000325	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SOCS1—psoriasis	8.61e-06	0.000314	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CXCL8—psoriasis	8.61e-06	0.000314	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.57e-06	0.000313	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	8.45e-06	0.000308	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	8.23e-06	0.0003	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TYK2—psoriasis	8.21e-06	0.0003	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—psoriasis	8.19e-06	0.000299	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—JUN—psoriasis	8e-06	0.000292	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CARM1—psoriasis	7.99e-06	0.000291	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	7.87e-06	0.000287	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	7.83e-06	0.000286	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NFKB1—psoriasis	7.7e-06	0.000281	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TYK2—psoriasis	7.58e-06	0.000277	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	7.47e-06	0.000273	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.46e-06	0.000272	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—psoriasis	7.32e-06	0.000267	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—psoriasis	7.32e-06	0.000267	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—psoriasis	7.26e-06	0.000265	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	7.16e-06	0.000261	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	7.15e-06	0.000261	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CAT—psoriasis	7.02e-06	0.000256	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—psoriasis	6.99e-06	0.000255	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—psoriasis	6.95e-06	0.000254	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—STAT3—psoriasis	6.92e-06	0.000253	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TYK2—psoriasis	6.92e-06	0.000253	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—psoriasis	6.91e-06	0.000252	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	6.82e-06	0.000249	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL8—psoriasis	6.6e-06	0.000241	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	6.5e-06	0.000237	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—psoriasis	6.35e-06	0.000232	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—psoriasis	6.35e-06	0.000232	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CAT—psoriasis	6.3e-06	0.00023	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—psoriasis	6.28e-06	0.000229	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CARM1—psoriasis	6.16e-06	0.000225	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CAT—psoriasis	6.15e-06	0.000224	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JUN—psoriasis	6.14e-06	0.000224	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL8—psoriasis	6.03e-06	0.00022	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PPARG—psoriasis	6.02e-06	0.00022	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	5.92e-06	0.000216	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NFKB1—psoriasis	5.91e-06	0.000216	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAT—psoriasis	5.8e-06	0.000212	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—psoriasis	5.78e-06	0.000211	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—psoriasis	5.78e-06	0.000211	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—psoriasis	5.73e-06	0.000209	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JUN—psoriasis	5.6e-06	0.000204	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TYK2—psoriasis	5.58e-06	0.000204	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—psoriasis	5.49e-06	0.0002	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—psoriasis	5.46e-06	0.000199	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NFKB1—psoriasis	5.39e-06	0.000197	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	5.39e-06	0.000197	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—psoriasis	5.36e-06	0.000196	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—psoriasis	5.31e-06	0.000194	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—psoriasis	5.28e-06	0.000193	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—psoriasis	4.91e-06	0.000179	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—psoriasis	4.9e-06	0.000179	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—psoriasis	4.89e-06	0.000179	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—psoriasis	4.86e-06	0.000177	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TYK2—psoriasis	4.85e-06	0.000177	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—psoriasis	4.85e-06	0.000177	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—psoriasis	4.84e-06	0.000176	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—psoriasis	4.78e-06	0.000174	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—psoriasis	4.75e-06	0.000173	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—psoriasis	4.62e-06	0.000169	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—psoriasis	4.52e-06	0.000165	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—psoriasis	4.5e-06	0.000164	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TYK2—psoriasis	4.41e-06	0.000161	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NFKB1—psoriasis	4.35e-06	0.000159	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—psoriasis	4.27e-06	0.000156	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—psoriasis	4.22e-06	0.000154	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—psoriasis	4.16e-06	0.000152	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—psoriasis	4.05e-06	0.000148	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—psoriasis	4.01e-06	0.000147	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—psoriasis	3.95e-06	0.000144	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—psoriasis	3.93e-06	0.000143	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—psoriasis	3.92e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—psoriasis	3.91e-06	0.000143	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	3.84e-06	0.00014	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—psoriasis	3.82e-06	0.000139	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—psoriasis	3.79e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKB1—psoriasis	3.78e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—psoriasis	3.71e-06	0.000135	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—psoriasis	3.7e-06	0.000135	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—psoriasis	3.65e-06	0.000133	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—psoriasis	3.57e-06	0.00013	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	3.44e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—psoriasis	3.43e-06	0.000125	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—psoriasis	3.4e-06	0.000124	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—psoriasis	3.39e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—psoriasis	3.32e-06	0.000121	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	3.12e-06	0.000114	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—psoriasis	3.09e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—psoriasis	2.98e-06	0.000109	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—psoriasis	2.95e-06	0.000107	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—psoriasis	2.73e-06	9.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—psoriasis	2.59e-06	9.46e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—psoriasis	2.57e-06	9.36e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—psoriasis	2.37e-06	8.65e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—psoriasis	2.36e-06	8.6e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—psoriasis	2.16e-06	7.87e-05	CbGpPWpGaD
